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Summary
	 Background:	 Damage	of	transplanted	organs	during	reperfusion	is	still	a	problem	that	prompts	the	search	for	
new	drugs	able	to	diminish	the	risk	of	graft	rejection.	The	aim	of	this	study	was	to	examine	the	
influence	of	antioxidant	system	on	the	contraction	of	arteries	induced	by	angiotensin	II	during	
ischemia/reperfusion	and	to	determine	the	role	of	intracellular	and	extracellular	calcium	ions	un-
der	these	conditions.
	 Material/Methods:	 The	experiments	were	performed	on	male	Wistar	rats’	tail	arteries.	The	effects	of	angiotensin	II	
on	vascular	tone	were	examined	after	ischemia/reperfusion	in	the	presence	of	catalase	or	amino-
triazole.	To	determine	the	role	of	intracellular	and	extracellular	Ca2+,	the	experiments	were	per-
formed	in	Ca2+-free	PSS	and	PSS.
	 Results:	 Angiotensin	II	increased	perfusion	pressure	in	both	Ca2+-free	PSS	and	PSS.	After	ischemia,	the	
reactions	induced	by	angiotensin	II	were	lower,	while	after	reperfusion	they	were	higher.	In	the	
presence	of	catalase	the	effects	induced	by	angiotensin	II	were	lower	and	in	the	presence	of	ami-
notriazole	higher.
	 Conclusions:	 Ischemia	inhibits	and	reperfusion	augments	the	perfusion	pressure	induced	by	angiotensin	II.	The	
results	confirm	the	vasoprotective	effect	of	catalase	and	the	destructive	influence	of	aminotriazo-
le	in	modulating	the	reactions	of	vascular	smooth	muscle	cells	to	ANG	II	after	ischemia/reper-
fusion.	These	results	suggest	that	the	antioxidant	system	plays	a	role	in	modulating	the	reactions	
induced	by	angiotensin	II	after	ischemia/reperfusion	and	that	reperfusion	disturbs	the	balance	
between	antioxidants	and	the	production	of	reactive	oxygen	species.
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Streszczenie
	 Wstęp:	 Uszkodzenia	przeszczepianych	narządów,	wyzwalane	reperfuzją,	stanowią	poważny	problem	
w	transplantologii	i	są	powodem	poszukiwania	leków,	które	zmniejszałyby	ryzyko	niepowodzeń,	
związanych	z	przywróceniem	przepływu	w	przeszczepie.	Celem	pracy	było	określenie	wpływu	
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The	blood	vessel	wall	is	an	active	structure	formed	by	cellu-
lar	elements	(endothelial	cells,	smooth	muscle	cells,	and	fi-
broblasts)	and	extracellular	matrix.	Its	components	undergo	
dynamic	changes	in	shape,	growth,	and	reorganization	un-
der	the	influence	of	stimulation	by	various	physiological	and	
pathological	factors	[8].	Smooth	muscle	performs	a	signifi-
cant	role	in	the	normal	function	of	blood	vessels,	accounting	
for	their	shrinkage,	growth,	remodeling,	and	repair.	It	also	
serves	a	role	in	the	pathogenesis	of	vascular	diseases	such	
as	atherosclerosis,	hypertension,	and	restenosis	[2,15,21].
The	contractility	of	blood	vessels	is	affected	by	their	pro-
per	structure	and	the	availability	of	calcium	ions.	Muscle	
action	is	regulated	by	a	number	of	local	and	systemic	fac-
tors,	such	as	vasoactive	peptides	which	contract	vessels	
(e.g.	angiotensin	II,	endothelin-1)	and	vasodilatory	substan-
ces	(e.g.	nitric	oxide,	prostacyclin)	[19,24,32].	Important	
for	this	process	are	also	pathological	processes,	such	as	
ischemia	and	reperfusion	(I/R)	and	oxidative	stress	[18].
Angiotensin	II	(ANG	II),	one	of	the	strongest	factors	shrin-
king	blood	vessels,	is	an	important	mediator	stimulating	the	
production	of	reactive	oxygen	species	(ROS)	and	the	activa-
tion	of	early	mechanisms	of	inflammation,	but	it	also	acti-
vates,	in	response	to,	among	others,	I/R,	the	transcription	of	
factors	that	promote	inflammation	and	performs	an	important	
role	in	the	pathophysiology	of	endothelial	dysfunction,	unsta-
ble	angina	pectoris,	acute	myocardial	infarction,	and	heart	fa-
ilure.	ANG	II-dependent	hypertension	models	indicate	that	
peroxide	anion	production	is	increased	as	a	result	of	the	acti-
vation	of	vascular	NADH/NADPH-oxidase	[17,18,37].	ROS	
generated	by	NADH/NADPH-oxidase	interact	in	vascular	hy-
pertrophy	mediated	by	ANG	II	in	hypertension.	The	inhibi-
tion	of	NADH/NADPH-oxidase	prevents	hypertrophy	of	va-
scular	smooth	muscle	cells	induced	by	ANG	II,	suggesting	a	
potential	role	of	ROS	as	stimulators	of	cell	growth	in	hyper-
tension	[34,35].	The	protective	effect	of	antioxidant	therapy	
against	the	action	of	hypertrophic	ANG	II	was	demonstrated.
Calcium	ions	perform	an	important	role	in	regulating	cell	
function.	The	level	of	free	calcium	ion	in	the	cytoplasm	is	
maintained	within	a	very	narrow	range;	ensuring	its	physio-
logical	function	as	a	signaling	system	in	the	cell.	Increased	
calcium	ion	concentration	also	occurs	in	pathological	si-
tuations,	such	as	hypoxia	and	ischemia,	whereby	cells	re-
ach	a	deficit	of	energy	[28].
The	conditions	for	I/R	develop	during	surgical	interven-
tions	such	as	bypass	operations	and	the	transplantation	of	
organs	and	may	be	responsible	for	impaired	function	or	
graft	rejection.	Tissue	damage	caused	by	hypoxia	depends	
on	mechanisms	associated	with	reactive	forms	of	oxy-
gen	(ROS)	and	nitrogen	(reactive	nitrogen	species,	RNS)	
[4,16].	The	damage	triggered	by	reperfusion	is	determined	
by	the	increase	in	the	mitochondrial	production	of	persi-
stent	and	diffusion	oxidants,	peroxides	and	the	release	of	
układu	antyoksydacyjnego	na	skurcz	tętnic	wyzwalany	przez	angiotensynę	II	po	niedokrwieniu	
i	reperfuzji,	z	uwzględnieniem	udziału	wewnątrzkomórkowej	i	zewnątrzkomórkowej	puli	jonów	
wapnia.
	Materiał/Metody:	 Badania	przeprowadzono	na	perfundowanych	tętnicach	ogonowych	szczurów,	samców	szczepu	
Wistar.	Badano	skurcz	wyzwalany	przez	angiotensynę	II	z	udziałem	wewnątrzkomórkowej	i	ze-
wnątrzkomórkowej	puli	jonów	wapnia	po	niedokrwieniu	i	reperfuzji	oraz	w	obecności	katalazy	
i	aminotriazolu.
	 Wyniki:	 Angiotensyna	II	wyzwala	wzrost	ciśnienia	perfuzyjnego	z	udziałem	wewnątrz-	i	zewnątrzko-
mórkowej	puli	jonów	wapnia.	Po	niedokrwieniu,	w	sposób	zależny	od	czasu	trwania,	dochodzi	
do	obniżenia	reakcji	mięśniówki	gładkiej	na	angiotensynę	II,	a	reperfuzja	prowadzi	do	nasilenia	
skurczu.	Obecność	katalazy	powoduje	obniżenie,	zaś	aminotriazolu	podwyższenie	reakcji	wy-
zwalanych	przez	angiotensynę	II.
	 Wnioski:	 Niedokrwienie	redukuje,	natomiast	reperfuzja	wzmaga	reakcję	tętnic	na	ANG	II.	Wyniki	potwier-
dzają	wazoprotekcyjne	działanie	katalazy	oraz	destrukcyjny	wpływ	aminotriazolu	w	modulowa-
niu	reakcji	mięśniówki	gładkiej	naczyń	na	ANG	II	po	niedokrwieniu/reperfuzji.	Wyniki	sugeru-
ją,	że	układ	antyoksydacyjny	moduluje	reakcje	wyzwalane	przez	ANG	II,	a	reperfuzja	zaburza	
równowagę	pomiędzy	antyoksydantami	i	produkcją	reaktywnych	form	tlenu.
  Słowa kluczowe:  angiotensyna II • niedokrwienie • reperfuzja • katalaza • aminotriazol
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Fig. 1.  Perfusion pressure induced by ANG II after 
ischemia (I)/reperfusion (R) mediated by 
intracellular (i.c. Ca2+) and extracellular (e.c. 
Ca2+) calcium ions (mean ±SE). *p<0.0001 vs. 
control, **0.05>p>0.0001 vs. control
H2O2,	which	activate	a	cell	signaling	system	or	react	with	
proteins	and	lipids	of	cell	membranes	[11].	The	activation	
of	neutrophils	significantly	contributes	to	deepening	the	
process	of	tissue	damage	associated	with	ischemia	and	re-
perfusion	of	blood	vessels	[11,25,36].	ROS	and	RNS	acti-
vate	mechanisms	which,	during	hypoxia	and	reperfusion,	
lead	to	cell	damage	and	trigger	signals	releasing	mediators.	
These	mediators	then	induce	apoptosis	or	cell	death	[38].
In	the	first	part	of	this	study	the	role	of	calcium	ions	and	the	
importance	of	G	protein	reactivity	of	arteries	triggered	by	
ANG	II,	phenylephrine,	and	Bay	K8644	after	I/R	were	eva-
luated.	The	aim	of	this	part	was	to	determine	the	influence	
of	the	antioxidant	system	on	arterial	contraction	triggered	by	
ANG	II	after	I/R,	including	the	involvement	of	intracellular	
and	extracellular	pools	of	calcium	ions	in	the	test	reactions.
MaterIal and Methods
The	experiments	were	performed	on	isolated	and	perfu-
sed	tail	artery	of	Wistar	rats	weighing	from	250	to	350	g	
and	euthanized	by	urethane	injected	intraperitoneally	at	a	
dose	of	120	mg/kg.	The	experiments	of	arterial	contrac-
tion	after	I/R	were	performed	using	the	same	method	and	
experimental	arrangement	as	in	Part	1.
To	assess	the	contribution	of	the	intracellular	(i.c.	Ca2+)	
and	extracellular	(e.c.	Ca2+)	pools	of	Ca2+	in	the	reactions	
triggered	by	ANG	II,	the	experiment	was	carried	out	using	
two	types	of	Krebs’	fluid:
•	 FPSS:	Ca2+-EGTA-free	Krebs’	fluid;
•	 	 PSS:	Ca2+-EGTA	Krebs’	fluid	(standard),	after	empty-
ing	the	intracellular	calcium	pools.
Contraction	was	triggered	using	the	AT1	receptor	agonist	
ANG	II.	Dependencies	for	the	test	conditions	in	the	pre-
sence	of	catalase	(500	U/ml)	and	aminotriazole,	an	inhi-
bitor	of	catalase	(10	mM/l),	and	after	ischemia	(30	and	
60	min.)	and	reperfusion	(30,	60,	and	120	min.)	were	de-
termined.	The	results	are	presented	as	mean	values	and	
standard	deviations.	Statistical	differences	were	assessed	
by	Student’s	t	test.	Values	were	considered	statistically	si-
gnificantly	different	with	p<0.05.	Calculations	were	per-
formed	with	the	program	Statistica	6.0	PL.
results
ANG	II	triggered	an	increase	in	perfusion	pressure	in	FPSS	
and	PSS,	with	higher	values	in	PSS	(Fig.	1).	After	30	and	
60	min.	of	ischemia,	reductions	in	the	response	of	arteries	
to	ANG	II	in	both	types	of	experiments	were	observed	and	
the	effect	depended	on	the	duration	of	ischemia.	In	PSS	
after	30,	60,	and	120	min.	of	reperfusion,	perfusion	pres-
sur	was	increased,	while	in	FPSS	perfusion	pressure	after	
reperfusion	was	less	pronounced.	The	perfusion	pressure	
values	triggered	by	ANG	II	after	I/R	in	FPSS	and	PSS	are	
presented	in	Figure	1.
In	the	presence	of	catalase	a	reduction	of	the	contracting	
action	of	ANG	II	is	observed.	The	values	of	perfusion	
pressure	after	reperfusion	were	lower	than	in	the	experi-
ments	without	this	enzyme.	The	effect	of	catalase	on	the	
contraction	of	blood	vessels	triggered	by	ANG	II	after	I/R	
in	FPSS	and	PSS	is	shown	in	Figure	2.
In	the	presence	of	aminotriazole,	arterial	reaction	invoked	
by	ANG	II	after	ischemia	and	reperfusion	is	higher.	Figure	
3	shows	the	perfusion	pressure	triggered	by	ANG	II	after	
I/R	in	FPSS	and	PSS	in	the	presence	of	aminotriazole.
dIscussIon
The	process	of	replantation	is	always	associated	with	a	period	
of	ischemia/hypoxia	and	reperfusion,	triggering	a	local	incre-
ase	in	vascular	resistance	and	a	reduction	of	the	transplanted	
organ’s	perfusion	[10,13].	Prolonged	ischemia	can	also	sub-
sequently	lead	to	the	total	diminishment	of	perfusion	of	the	
transplanted	organ.	The	increase	in	tonic	tension	of	smooth	
muscle	after	I/R,	as	demonstrated	by	studies,	leads	to	an	un-
controlled	increase	in	Ca2+	ion	concentration	and	to	damage	to	
endothelial	cells	and	smooth	muscle	and,	afterwards,	distur-
bances	in	the	balance	between	modulating	factors	and	the	trig-
gering	of	vessel	contraction	and	vasodilation	factors	[7,13,14].
In	recent	years,	ROS	were	examined	for	their	significance	
as	part	of	the	cell	signaling	system	[9,23,27].	It	was	de-
monstrated	that	ROS	can	induce	cell	proliferation	because	
it	influences	the	intracellular	mechanisms	associated	with	
activation	of	the	cell	cycle	[3,22,33].
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its	inhibitor,	aminotriazole,	on	arterial	reactions	triggered	
by	ANG	II	after	I/R.	To	determine	the	importance	of	cal-
cium	ions	(from	intracellular	stores	and	extracellular	flu-
id),	the	experiments	were	carried	out	in	a	calcium	ion-free	
liquid	(to	evaluate	the	importance	of	the	intracellular	pool)	
and	in	a	standard	Krebs’	liquid	after	emptying	the	stores	of	
cellular	calcium	(to	assess	the	participation	of	the	extra-
cellular	pool).	In	this	study	the	artery	contraction	trigge-
red	by	ANG	II	through	the	agency	of	the	intracellular	and	
extracellular	pools	of	calcium	ions	and	the	reaction	in	PSS	
was	more	significant	for	research.	The	study	provided	data	
indicating	a	reduction	of	vascular	reactions	with	ANG	II	
after	ischemia	and	a	subsequent	increase	in	the	vascular	
reactions	to	this	peptide	during	reperfusion.
It	was	demonstrated	that	the	inhibitory	effect	on	artery	con-
traction	is	associated	with	the	presence	of	endothelium,	the	
synthesis	of	nitric	oxide,	and	the	activation	of	cGMP	[30].	
In	the	modulations	of	the	arteries’	responses	to	ANG	II,	
ROS	reacts	in	an	antagonistic	way	to	NO.
The	present	study	indicated	that	artery	contraction	trig-
gered	by	ANG	II	in	the	presence	of	catalase	is	reduced.	
Comparison	of	the	effect	of	catalase	with	the	influence	of	
an	inhibitor	of	this	enzyme,	aminotriazole,	showed	that	in-
hibition	of	this	enzyme	causes	a	significant	increase	in	the	
response	to	ANG	II.	The	reported	results	as	well	as	those	
of	Aoshiba	et	al.	[1]	confirm	the	protective	effect	of	cata-
lase	(as	well	as	the	destructive	action	of	aminotriazole)	and	
its	role	in	preventing	an	excessive	increase	in	ROS.	Under	
ischemic	conditions,	catalase	did	not	significantly	affect	
the	responses	to	ANG	II.	Catalase	reduces	the	modulating	
reperfusion	effect	on	the	reactions	triggered	by	ANG	II,	le-
ading	to	a	reduction	of	the	maximum	reactions	obtained.
Aminotriazole	diminishes	the	inhibitory	effect	of	30	and	
60	min.	of	ischemia	on	the	artery	responses	to	ANG	II.	In	
reperfusion,	in	contrast,	significant	intensification	of	the	
reactions	to	ANG	II	was	observed	especially	in	the	expe-
riments	with	the	participation	of	the	extracellular	pool	of	
calcium	ions.	Similar	observations	come	from	studies	of	
artery	reactivity	after	I/R	triggered	by	increasing	concen-
trations	of	ANG	II	[31].
The	presented	results	confirm	the	participation	of	catalase	
in	modulating	reactions	during	ischemia	and	reperfusion.	
Catalase	as	well	as	SOD	is	a	metalloprotein	which	dimi-
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Fig. 2.  Perfusion pressure induced by ANG II in the 
presence of catalase (CAT) after ischemia (I)/
reperfusion (R) mediated by intracellular (i.c. 
Ca2+) and extracellular (e.c. Ca2+) calcium 
ions (mean ±SE). *p<0.0001 vs. control, 
**0.05>p>0.0001 vs. control
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Fig. 3.  Perfusion pressure induced by ANG II in the 
presence of aminotriazole (AMT) after ischemia 
(I)/reperfusion (R) mediated by intracellular 
(i.c. Ca2+) and extracellular (e.c. Ca2+) calcium 
ions (mean ±SE). *p<0.0001 vs. control, ** 
0.05>p>0.0001 vs. control
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zymes	to	reduce	damage	induced	by	I/R	and	ROS	caused	
different	effects	[6,12,29].	However,	low-molecular-we-
ight	substances	imitating	the	action	of	SOD	(SOD	mimics,	
SODm)	indicate	experimental	models	of	the	potential	anti-
inflammatory	effects	limiting	the	damage	triggered	by	I/R	
and	prolonging	the	half	time	of	NO,	anticoagulant,	and	re-
laxing	action.	SODm	can	therefore	be	applied	in	the	futu-
re	to	treat	diseases	such	as	inflammation,	shock,	and	da-
mage	triggered	by	I/R	[5,20,26].
conclusIons
Ischemia	reduces	while	reperfusion	enhances	the	respon-
se	of	arteries	to	ANG	II.	The	results	confirm	the	vasopro-
tective	action	of	catalase	and	the	destructive	influence	of	
aminotriazole	in	modulating	the	reaction	of	vascular	smo-
oth	muscle	to	ANG	II	after	I/R.	The	results	suggest	that	the	
antioxidant	system	modulates	the	responses	triggered	by	
ANG	II	and	reperfusion	impairs	the	balance	between	an-
tioxidants	and	the	production	of	reactive	oxygen	species.
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